Due to treatment costs and lack of reimbursement, community hospitals are charged with implementing innovative strategies that will reduce the incidence of hospital-acquired catheter-associated urinary tract infections (CAUTI).
Urinary tract infections account for 8%-21% of health care-associated infections; of these, 80% are associated with the use of a urinary catheter.
A quasi-experimental study was conducted in 2 medical-surgical intensive care units (ICUs) with 48 beds and 3 step-down units (SDUs) with 95 beds in a private tertiary care hospital in Sao Paulo, Brazil.
Catheter-associated urinary tract infections (CAUTI) account for ∼40% of all hospital-acquired infections worldwide, with more than one million cases diagnosed annually. Recent data from a CAUTI animal model has shown that inflammation induced by catheterization releases host fibrinogen that accumulates on the catheter.
BACKGROUND - To report the results of the International Nosocomial Infection Control Consortium (INICC) multicenter study conducted in Mongolia from September 2013-March 2015.
METHODS - A device-associated health care-associated infection prospective surveillance study in 3 adult intensive care units (ICUs) from 3 hospitals using the U.
To estimate differences in the length of stay (LOS) and costs for comparable pediatric patients with and without venous thromboembolism (VTE), catheter-associated urinary tract infection (CAUTI), and pressure ulcer (PU).
Catheter-associated urinary tract infection (CAUTI) is an important patient safety issue that is responsible for an estimated 449334 annual infections, with an average direct cost of $790-$1200 per infection.
OBJECTIVE - Catheter-associated urinary tract infections (CAUTIs) are the most common nosocomial acquired infections, with high resistance rates. CAUTIs are a potentially severe complication in hospitalized patients and imply higher costs. Our aim was to analyze the characteristics of CAUTIs in our Urology department.
OBJECTIVE - To delineate the epidemiology of catheter-associated urinary tract infections (CAUTIs) and to better understand the value of urine cultures for evaluation of fever in the intensive care unit (ICU) setting
Catheter-associated urinary tract infections (CAUTIs) occur in 290,000 US hospital patients annually, with an estimated cost of $290 million.
The effectiveness of continuous nationwide surveillance on healthcare-associated infections should be investigated in each country.
A collaborative effort reduced catheter-associated urinary tract infections in the neuro-spine intensive care unit where the majority of infections occurred at our institution.
Device-associated health care-acquired infections (DA-HAIs) pose a threat to patient safety, particularly in the intensive care unit (ICU).
BACKGROUND: Incidence of catheter-associated urinary tract infection (CAUTI) is a quality benchmark.
IMPORTANCE: Overtreatment of asymptomatic bacteriuria (ASB) in patients with urinary catheters remains high.
BACKGROUND: Critically ill patients are at marked risk of hospital-acquired infections, which increase patients' morbidity and mortality.
BACKGROUND: Catheter-associated candiduria is a common clinical finding in hospitalized patients, especially in the intensive care unit.
BACKGROUND: The 2008 Centers for Medicare & Medicaid Services hospital-acquired conditions policy limited additional payment for conditions deemed reasonably preventable.
Inpatients in the intensive care unit (ICU) are at high risk for healthcare-associated infections (HAIs).
BACKGROUND: Numerous initiatives have focused on reducing device-associated infections, contributing to an overall decrease in infections nationwide.
PURPOSE: Catheter-associated urinary tract infections (CAUTI) are an essential measure for health care quality improvement that affects reimbursement through hospital-acquired condition reduction programs in adult patients.
